| 2012 |
05/14/12 |
Critical Diagnostics Extends Its Asia Pacific Reach |
|
05/01/12 |
HDL to Offer Presage ST2 Assay |
|
04/11/12 |
ST2 Bests BNP in Identifying Patients with Heart Failure |
|
03/12/12 |
Critical Diagnostics Expands in Asia |
|
02/28/12 |
Panel of Biomarkers Proves Useful in Predicting Chronic Heart Failure Outcomes |
|
02/12/12 |
ST2 Predicts Worsening HF and Mortality in the CORONA Study |
|
01/02/12 |
Presage® ST2 Assay Enters Routine Use |
| 2011 |
12/15/11 |
FDA Clearance for Presage® ST2 Assay for Patients with Heart Failure |
|
08/31/11 |
New Clinical Evidence for ST2 Reported at 2011 ESC Congress |
|
08/16/11 |
Issuance of a U.S. Patent for ST2 Testing and Sales in Europe |
|
06/09/11 |
ESC-HF 2011: ST2 Predicts Outcomes in Ambulatory HF Patients |
|
04/01/11 |
ACC 2011: ST2 Predicts Outcomes in MI and in Advanced HF |
|
01/17/11 |
ST2 Predicts Outcomes in Chronic Heart Failure |
|
01/07/11 |
Critical Diagnostics Receives CE Mark for Presage® ST2 Assay |
| 2010 |
11/18/10 |
AHA 2010: Studies Advance Prognostic Value of ST2 |
| |
10/31/10 |
ST2 Risk-Stratifies Ambulatory and Acute Patients |
| |
07/21/10 |
Presage™ ST2 Assay Validated |
| |
05/31/10 |
ST2 Predicts Outcomes in NSTEMI Patients in GUSTO IV |
| |
03/14/10 |
ACC 2010: ST2 Prognostic in Acute Dyspnea |
| |
02/11/10 |
ST2 Superior to Other Biomarkers; ST2/IL-33 Cardioprotective Mechanism Confirmed |
| |
02/03/10 |
US Patents Granted for ST2; ST2 Predicts Post-MI Response |
| 2009 |
12/01/09 |
ST2 Predicts Sudden Cardiac Death in Chronic Heart Failure |
| |
11/16/09 |
ST2 Prognostic in Ambulatory Echo Patients |
| |
09/20/09 |
ST2 Predicts Heart Transplant Rejection |
| |
08/01/09 |
Pat Arensdorf to Lead Critical Diagnostics |
| |
07/15/09 |
ST2 Prognostic of Long-Term Mortality in Acute Dyspnea |
| |
03/31/09 |
Presage™ ST2 Biomarker Meets High Quality Standards |
| 2008 |
11/24/08 |
ST2 Adds Monitoring Value in Heart Failure |
| |
10/28/08 |
ST2 Informs Care in Acute Decompensated Heart Failure |
| |
04/15/08 |
ST2 Provides Prognosis in Heart Failure and Heart Attack |
| |
01/02/08 |
ST2 Potential: Improved Outcomes and Reduced Costs |
| Pre-2008 |
08/07/07 |
ST2 Predicts Mortality in Dyspneic Patients |
| |
08/11/05 |
James Snider Named President of Critical Diagnostics |
| |
10/18/04 |
Critical Diagnostics Secures Seed Financing |
Back to Top 